GMED or MASI: Which Is the Better Value Stock Right Now?

Investors looking for stocks in the Medical - Instruments sector might want to consider either Globus Medical (GMED) or Masimo (MASI). But which of these two stocks is more attractive to value investors?

Zacks Investment Research • Feb 23, 2026

Here's Why Masimo (MASI) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Feb 20, 2026

Naya Capital Adds Masimo Shares

The firm initiated a new position by purchasing about 1.6 million shares. It position equals 15.3% of the fund's 13F assets under management.

The Motley Fool • Feb 19, 2026

Masimo's Board Backs Danaher's $9.9B Cash Acquisition Proposal

MASI will be acquired by Danaher for $9.9B in cash, sending shares soaring as the medtech firm prepares to join DHR's Diagnostics segment.

Zacks Investment Research • Feb 19, 2026

What's Happening With Masimo Stock?

Masimo stock (MASI) has faced a challenging year, trailing the broader market with a -3% annual return. While shares surged 34% yesterday following news of an acquisition by Danaher, this spike only partially offsets a period of long-term stagnation.

Forbes • Feb 18, 2026

Strength Seen in Masimo (MASI): Can Its 34.2% Jump Turn into More Strength?

Masimo (MASI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Investment Research • Feb 18, 2026

Top 3 Health Care Stocks That May Collapse This Quarter

As of Feb. 18, 2026, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

Benzinga • Feb 18, 2026

Masimo Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Masimo Corporation - MASI

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Masimo Corporation (NasdaqGS: MASI) to Danaher Corporation (NYSE: DHR). Under the terms of the proposed transaction, shareholders of Masimo will receive $180.00 in cash for each share of Masimo that they own. KSF is seeking to determine whether this consideration and the process that led to it are a.

Business Wire • Feb 19, 2026

SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Masimo Corporation (NASDAQ: MASI)

NEW YORK, Feb. 17, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. The firm is headquartered at the Empire State Building in New York City and is investigating Masimo Corporation (NASDAQ: MASI) related to its sale to Danaher Corporation.

PRNewsWire • Feb 17, 2026

MASI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Masimo Corporation to Danaher Corporation

MONSEY, N.Y., Feb. 17, 2026 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating the fairness of the proposed sale of Masimo Corporation (Nasdaq: MASI) (“Masimo”) for $180.00 per share in cash to Danaher Corporation (“Danaher”).

GlobeNewsWire • Feb 17, 2026